WHO named vaccine hesitancy a top 10 threat to global health in 2019. Hysteresis may describe persistent skepticism.
A new review from the American Medical Association addresses best practices for the evaluation and management of reported penicillin allergies.
Adults hospitalized for pneumonia who received an influenza vaccination during their stay were less likely to seroconvert if they had diabetes, bacterial detection, baseline seropositive titers for influenza B, or influenza vaccination in the previous season.
The quadrivalent LAIV4 is less effective than IIV against influenza A/H1N1pdm09 in all pediatric age groups.
Providers believe stressing fetal protection is most effective strategy against refusal.
The study utilized the Vaccine Safety Datalink and included children who received the first dose of a measles-containing vaccine between 12 and 23 months old during the study period of January 1, 2003 to September 20, 2015.
However, adjuvant recombinant subunit vaccine tied to more injection site adverse events.
Influenza Vaccines May Protect Against Lab-Confirmed Influenza-Linked Hospitalization During PregnancyNovember 07, 2018
For women who are pregnant, influenza vaccines may moderately protect against laboratory-confirmed influenza-associated hospitalization.
A second dose of Tdap, a reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine, 9 years after initial vaccination was well tolerated and immunogenic.
Prior-season vaccination is not associated with reduced vaccine effectiveness among children aged 2 to 17 years.
Health officers and immunization staff reported concerns including an increase in medical exemptions.
Research results indicated vaccination rates declined as clinic day progressed and that active choice intervention was linked with increased vaccinations.
While primary care physicians overwhelmingly recommend pneumococcal vaccines, there is a gap in their knowledge of how to implement related vaccine recommendations.
In-hospital postnatal education about infant pain management at vaccinations leads to more frequent use of pain relief interventions
Third Trimester Immunization With Tdap Vaccine Optimal for Pertussis Toxin Antibody Concentrations in NewbornsOctober 19, 2018
Immunization with Tdap vaccine during the third trimester of pregnancy resulted in higher concentrations of pertussis toxin antibodies in newborns.
The burden of childhood and infant pneumonia can be effectively reduced through the use of the pneumococcal Haemophilus influenzae protein D conjugate vaccine.
The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.
Active Choice Intervention Effective in Increasing Influenza Vaccination Rates at Primary Care PracticesOctober 05, 2018
Influenza vaccination rates decline as the clinic day progresses.
Monovalent Acellular Pertussis Vaccine Safe and Effective for Neonates With Mothers Unvaccinated for TdapOctober 03, 2018
The monovalent acellular pertussis vaccine may be beneficial to neonates whose mothers did not receive Tdap vaccine during pregnancy.
From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.
High population immunity is an indicator of the decline in serotype 2 Sabin vaccine poliovirus after serotype 2 oral poliovirus vaccine withdrawal.
No association was observed between prenatal vaccination of Tdap vaccination and an increased risk of autism spectrum disorder risk in children.
All children age 6 months and older, including teens, advised to undergo annual immunization.
Specimens of the rapidly evolving virus are needed to develop vaccines and treatments.
Due to a gap in knowledge regarding serogroup B meningococcal (MenB) disease and vaccination, the majority of clinicians are not discussing MenB vaccines with their adolescent patients during routine visits.
In general, routine annual vaccination is recommended for all patients ≥6 months of age who have no contraindications.
A malaria transmission-blocking vaccine, Pfs25H-EPA in Alhydrogel®, was well tolerated and safe and induced significant blockage of parasite transmission, but this activity was only seen at peak titers after 4 vaccine doses.
What's the best way to tell your anti-vaccine patients the truth about vaccines?